PDB Short entry for 3IKG HEADER ISOMERASE 05-AUG-09 3IKG TITLE STRUCTURE-BASED DESIGN OF NOVEL PIN1 INHIBITORS (I) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 45-163, PIN1 PPIASE DOMAIN; COMPND 5 SYNONYM: ROTAMASE PIN1, PPIASE PIN1; COMPND 6 EC: 5.2.1.8; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PIN1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SBDD, PPIASE, CELL CYCLE, ISOMERASE, SMALL MOLECULE, NUCLEUS, KEYWDS 2 PHOSPHOPROTEIN, ROTAMASE, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.PARGE,R.A.FERRE,S.GREASLEY,D.MATTHEWS REVDAT 5 06-SEP-23 3IKG 1 REMARK REVDAT 4 13-OCT-21 3IKG 1 REMARK SEQADV REVDAT 3 24-JAN-18 3IKG 1 AUTHOR REVDAT 2 30-MAR-16 3IKG 1 REMARK VERSN REVDAT 1 22-SEP-09 3IKG 0 JRNL AUTH C.GUO,X.HOU,L.DONG,E.DAGOSTINO,S.GREASLEY,R.FERRE, JRNL AUTH 2 J.MARAKOVITS,M.C.JOHNSON,D.MATTHEWS,B.MROCZKOWSKI,H.PARGE, JRNL AUTH 3 T.VANARSDALE,I.POPOFF,J.PIRAINO,S.MARGOSIAK,J.THOMSON,G.LOS, JRNL AUTH 4 B.W.MURRAY JRNL TITL STRUCTURE-BASED DESIGN OF NOVEL HUMAN PIN1 INHIBITORS (I). JRNL REF BIOORG.MED.CHEM.LETT. V. 19 5613 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19729306 JRNL DOI 10.1016/J.BMCL.2009.08.034 REMARK 2 REMARK 2 RESOLUTION. 1.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NONE SELECTED REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.206 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.206 REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 0.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 18140 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.190 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 0.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 15581 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1781 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 167 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2001.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 8007 REMARK 3 NUMBER OF RESTRAINTS : 7470 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 ANGLE DISTANCES (A) : 0.020 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.026 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.029 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.035 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.019 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.076 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3IKG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-AUG-09. REMARK 100 THE DEPOSITION ID IS D_1000054523. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JUN-00 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC BLUE REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18140 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.860 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 4.390 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.40400 REMARK 200 R SYM FOR SHELL (I) : 0.40400 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: PDB ENTRY 3IK8 APO PPIASE K7782Q REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE, 0.9M NA REMARK 280 CITRATE, 5MM TCEP, 100MM HEPES: COMPOUND @ 500UM SOAKED INTO APO REMARK 280 CRYSTAL FOR 60HRS. , PH 8.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 59.12750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.26500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 59.12750 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 18.26500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 205 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 232 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 41 REMARK 465 SER A 42 REMARK 465 HIS A 43 REMARK 465 MET A 44 REMARK 465 GLY A 45 REMARK 465 LYS A 46 REMARK 465 ASN A 47 REMARK 465 GLY A 48 REMARK 465 GLN A 49 REMARK 465 GLY A 50 REMARK 465 GLY B 41 REMARK 465 SER B 42 REMARK 465 HIS B 43 REMARK 465 MET B 44 REMARK 465 GLY B 45 REMARK 465 LYS B 46 REMARK 465 ASN B 47 REMARK 465 GLY B 48 REMARK 465 GLN B 49 REMARK 465 GLY B 50 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE B 156 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 165 O HOH B 205 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 80 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ARG B 74 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE J8Z A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE J8Z B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3I6C RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH SMALL MOLECULE INHIBITOR REMARK 900 RELATED ID: 3IK8 RELATED DB: PDB REMARK 900 SAME PROTEIN: APO STRUCTURE REMARK 900 RELATED ID: 3IKD RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH SMALL MOLECULE INHIBITOR DBREF 3IKG A 45 163 UNP Q13526 PIN1_HUMAN 45 163 DBREF 3IKG B 45 163 UNP Q13526 PIN1_HUMAN 45 163 SEQADV 3IKG GLY A 41 UNP Q13526 EXPRESSION TAG SEQADV 3IKG SER A 42 UNP Q13526 EXPRESSION TAG SEQADV 3IKG HIS A 43 UNP Q13526 EXPRESSION TAG SEQADV 3IKG MET A 44 UNP Q13526 EXPRESSION TAG SEQADV 3IKG GLN A 77 UNP Q13526 LYS 77 ENGINEERED MUTATION SEQADV 3IKG GLN A 82 UNP Q13526 LYS 82 ENGINEERED MUTATION SEQADV 3IKG GLY B 41 UNP Q13526 EXPRESSION TAG SEQADV 3IKG SER B 42 UNP Q13526 EXPRESSION TAG SEQADV 3IKG HIS B 43 UNP Q13526 EXPRESSION TAG SEQADV 3IKG MET B 44 UNP Q13526 EXPRESSION TAG SEQADV 3IKG GLN B 77 UNP Q13526 LYS 77 ENGINEERED MUTATION SEQADV 3IKG GLN B 82 UNP Q13526 LYS 82 ENGINEERED MUTATION SEQRES 1 A 123 GLY SER HIS MET GLY LYS ASN GLY GLN GLY GLU PRO ALA SEQRES 2 A 123 ARG VAL ARG CYS SER HIS LEU LEU VAL LYS HIS SER GLN SEQRES 3 A 123 SER ARG ARG PRO SER SER TRP ARG GLN GLU GLN ILE THR SEQRES 4 A 123 ARG THR GLN GLU GLU ALA LEU GLU LEU ILE ASN GLY TYR SEQRES 5 A 123 ILE GLN LYS ILE LYS SER GLY GLU GLU ASP PHE GLU SER SEQRES 6 A 123 LEU ALA SER GLN PHE SER ASP CYS SER SER ALA LYS ALA SEQRES 7 A 123 ARG GLY ASP LEU GLY ALA PHE SER ARG GLY GLN MET GLN SEQRES 8 A 123 LYS PRO PHE GLU ASP ALA SER PHE ALA LEU ARG THR GLY SEQRES 9 A 123 GLU MET SER GLY PRO VAL PHE THR ASP SER GLY ILE HIS SEQRES 10 A 123 ILE ILE LEU ARG THR GLU SEQRES 1 B 123 GLY SER HIS MET GLY LYS ASN GLY GLN GLY GLU PRO ALA SEQRES 2 B 123 ARG VAL ARG CYS SER HIS LEU LEU VAL LYS HIS SER GLN SEQRES 3 B 123 SER ARG ARG PRO SER SER TRP ARG GLN GLU GLN ILE THR SEQRES 4 B 123 ARG THR GLN GLU GLU ALA LEU GLU LEU ILE ASN GLY TYR SEQRES 5 B 123 ILE GLN LYS ILE LYS SER GLY GLU GLU ASP PHE GLU SER SEQRES 6 B 123 LEU ALA SER GLN PHE SER ASP CYS SER SER ALA LYS ALA SEQRES 7 B 123 ARG GLY ASP LEU GLY ALA PHE SER ARG GLY GLN MET GLN SEQRES 8 B 123 LYS PRO PHE GLU ASP ALA SER PHE ALA LEU ARG THR GLY SEQRES 9 B 123 GLU MET SER GLY PRO VAL PHE THR ASP SER GLY ILE HIS SEQRES 10 B 123 ILE ILE LEU ARG THR GLU HET J8Z A 1 27 HET J8Z B 2 27 HETNAM J8Z (2R)-2-[(1-BENZOTHIOPHEN-2-YLCARBONYL)AMINO]-3-(3- HETNAM 2 J8Z METHYLPHENYL)PROPYL PHOSPHATE FORMUL 3 J8Z 2(C19 H18 N O5 P S 2-) FORMUL 5 HOH *167(H2 O) HELIX 1 1 THR A 81 GLY A 99 1 19 HELIX 2 2 ASP A 102 SER A 111 1 10 HELIX 3 3 CYS A 113 ARG A 119 5 7 HELIX 4 4 GLN A 131 LEU A 141 1 11 HELIX 5 5 THR B 81 SER B 98 1 18 HELIX 6 6 ASP B 102 SER B 111 1 10 HELIX 7 7 CYS B 113 ARG B 119 5 7 HELIX 8 8 GLN B 131 ALA B 140 1 10 SHEET 1 A 4 ASP A 121 SER A 126 0 SHEET 2 A 4 ARG A 54 VAL A 62 -1 N CYS A 57 O LEU A 122 SHEET 3 A 4 GLY A 155 GLU A 163 -1 O ILE A 156 N VAL A 62 SHEET 4 A 4 VAL A 150 THR A 152 -1 N VAL A 150 O HIS A 157 SHEET 1 B 4 ASP B 121 PHE B 125 0 SHEET 2 B 4 VAL B 55 VAL B 62 -1 N VAL B 55 O PHE B 125 SHEET 3 B 4 GLY B 155 GLU B 163 -1 O LEU B 160 N SER B 58 SHEET 4 B 4 VAL B 150 THR B 152 -1 N VAL B 150 O HIS B 157 SITE 1 AC1 12 HIS A 59 LYS A 63 ARG A 68 ARG A 69 SITE 2 AC1 12 CYS A 113 SER A 114 LEU A 122 MET A 130 SITE 3 AC1 12 PHE A 134 SER A 154 HIS A 157 HOH A 215 SITE 1 AC2 14 HOH B 36 HIS B 59 LEU B 61 LYS B 63 SITE 2 AC2 14 ARG B 68 ARG B 69 CYS B 113 SER B 115 SITE 3 AC2 14 LEU B 122 GLN B 131 PHE B 134 SER B 154 SITE 4 AC2 14 HIS B 157 HOH B 199 CRYST1 118.255 36.530 51.320 90.00 100.40 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008456 0.000000 0.001552 0.00000 SCALE2 0.000000 0.027375 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019811 0.00000